An oncologist who serves on the President's National Bioethics
Advisory Commission is new director of the Clinical Center's
department of clinical bioethics. Dr. Ezekiel J. Emanuel comes to
the CC from Dana-Farber Cancer Institute at Harvard, where he
has served as assistant professor of medicine and associate
professor of social medicine and of clinical epidemiology. He edits
the Journal of Clinical Oncology's "Ethics Rounds," and is associate
editor of the Journal of Clinical Ethics. Among his numerous
publications is a book, The Ends of Human Life: Medical Ethics in a
Liberal Polity. He initially will serve part-time as a senior consultant
for clinical bioethics and takes over the program full-time in 1997.
Michael I. Goldrich has been named deputy director of the
Clinical Center. He will function as the CC's chief operating officer.
He comes from NIAID, where he had served as director for
management and operations since 1984 and most recently as deputy
director. He holds a baccalaureate from the University of Maryland
and earned an MBA summa cum laude from Loyola University. He
came to NIH as a financial management trainee in 1971 and worked
as a grants specialist, financial management analyst, and senior
administrative officer at NCI before joining NIAID.
Dr. Sholom Wacholder, a mathematical statistician in the
Biostatistics Branch of NCI's Division of Cancer Epidemiology and
Genetics, has been named a fellow of the American Statistical
Association. The designation of fellow recognizes outstanding
professional contribution and leadership in the field of statistical
science.
Up to Top